BiotechTube

Nasopharyngeal Carcinoma

9 competing products in clinical development for Nasopharyngeal Carcinoma.

Pipeline by Phase

Phase 11
Phase 21
Phase 37

All Products (9)

ProductCompanyStageStatusHype
5-fu + Lobaplatin + Placebo + leucogenSun PharmaceuticalPhase 3Recruiting
47
PD-1 blocking antibody + Gemcitabine + Cisplatin (80 mg/m2) + Cisplatin (100 mg/m2) + CapecitabineSun PharmaceuticalPhase 3Recruiting
47
docetaxel, nedaplatin, and capecitabine + nedaplatin + docetaxel, cisplatin, and fluorouracil + cisplatin + docetaxel, cisplatin, and capecitabine + docetaxel, nedaplatin, and fluorouracilSun PharmaceuticalPhase 3Recruiting
47
Nedaplatin + CisplatinSun PharmaceuticalPhase 3Completed
40
CisplatinSun PharmaceuticalPhase 3UNKNOWN
36
Cisplatin 1 + Cisplatin 2 + Docetaxel + XelodaSun PharmaceuticalPhase 3UNKNOWN
36
CapecitabineSun PharmaceuticalPhase 3UNKNOWN
36
Cisplatin 2 + Docetaxel + Cisplatin 1Sun PharmaceuticalPhase 2UNKNOWN
31
Nanatinostat + Valganciclovir + PembrolizumabViracta TherapeuticsPhase 1Terminated
11